Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. It operates through the following segments: dCELL, BioRinse, GBM-V, and Central. The dCELL segment technology platform removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold. The BioRinse segment offers sterile tissue prepared in a manner to minimise the negative effects of processing. The GBM-V segment is a regional tissue bank based in Rostock, Germany, which currently produces tissue preparations for ophthalmology. The company was founded by Eileen Ingham and John Fisher in May 2006 and is headquartered in Leeds, the United Kingdom.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Tissue Regenix Group Plc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tissue Regenix Group Plc market cap is $35.1M.
What is the 52-week high for Tissue Regenix Group Plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tissue Regenix Group Plc 52 week high is $0.005 as of September 06, 2025.
What is the 52-week low for Tissue Regenix Group Plc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tissue Regenix Group Plc 52 week low is $0.005 as of September 06, 2025.
What is Tissue Regenix Group Plc stock price today?
Tissue Regenix Group Plc stock price today is $0.005.
What was Tissue Regenix Group Plc stock price yesterday?
Tissue Regenix Group Plc stock price yesterday was $0.005.
What is the PE ratio of Tissue Regenix Group Plc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tissue Regenix Group Plc’s P/E ratio is -0.03.
What is the Price-to-Book ratio of Tissue Regenix Group Plc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tissue Regenix Group Plc P/B ratio is 0.0110.
What is the 50-day moving average of Tissue Regenix Group Plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tissue Regenix Group Plc 50-day moving average is $0.005.